Progress on EUnetHTA JA3 - European Commission · Presentation title maximum three lines Press...

To view drawing guides

1.Right-click on slide and

select ’Grid and Guides...’

2.Check ’Display drawing

guides on screen’

3.Select ’OK’

Presentation title

maximum three lines

Press ‘Caps locked’

for title in Caps

Presentation subtitle

maximum three lines

of text

Progress on EUnetHTA JA3

Wim Goettsch

Health Care Institute, Diemen, NL Future Coordinator EUnetHTA JA3

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu 1

Brussels, May 23, 2016

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu

Maximum two

lines in header


for title in Caps

Text starts with no-bullet

To add pre-formatted

bullet text please use the

Increase/Decrease Indent

buttons found in the

Top-PowerPoint menu

Contents presentation

May 23, 2016 2


˗ Progress

˗ Content

˗ Involvement stakeholders

˗ Q&A


Maximum two

lines in header


for title in Caps






Top-PowerPoint menu

Short update on progress

May 23, 2016 3


˗ First submission of the JA3 proposal on January 26, 2016

˗ Meeting at CHAFEA in Luxembourg at February 5, 2016

˗ Formal comment document was received on February 29, 2016

˗ Kick-off meeting on March 3 in Amsterdam

˗ Submission of adapted JA3 proposal by e-mail on March 31, 2016


Maximum two

lines in header


for title in Caps






Top-PowerPoint menu

Overall comments CHAFEA/SANTE/External

May 23, 2016 4


˗ Overall scores were sufficient

˗ More clarification on role stakeholders

˗ Remarks on role liaison committee

˗ More clarity on the content of some WPs

˗ Specification of the roles of certain partners

˗ Focus on the number/definition of joint pilots

˗ More information needed on division of funding (between partners and between coordination and production)


Maximum two

lines in header


for title in Caps






Top-PowerPoint menu

Issues

May 23, 2016 5


˗Manageability of process with 77 partners

˗Issues with final submissions but also urgent issues for partners regarding formal requirements (LEAR, LSIGN, FSIGN)

˗ Changing perspectives on the necessity of having evaluation and dissemination WPs

˗ Changing perspectives on the role of affiliated entities

˗ Discussion on the retroactivity


Maximum two

lines in header


for title in Caps






Top-PowerPoint menu

Progress

May 23, 2016 6


˗ Move forward on the process of grant agreement and consortium agreement

˗ ZIN has started official recruitment for secretariat

˗ Planned transfer websites before the end of May.

˗ Foreseen starting date JA3 June 1 (signature probably a little bit later)

˗ First Ex Board meeting face to face June 14 in Diemen


Maximum two

lines in header


for title in Caps

Change fact box colour

Click on box, choose between

the five highlighted colours

under Shape fill






Top-PowerPoint menu

- To increase use, quality and efficiency of joint HTA work at

European level:

- To support evidence-based, sustainable and equitable choices in

healthcare

- To ensure re-use in regional and national HTA reports

- To avoid duplication of assessments

˗ To support structural voluntary cooperation at scientific and

technical level between HTA bodies

- To propose a sustainable model for the scientific and technical

mechanism of a permanent European cooperation on HTA (2020

onwards)

Objectives of EUnetHTA JA3 (2016-2020)


7


Maximum two

lines in header


for title in Caps


Change Country colour

Click twice on country,

choose between the five

highlighted colours

under Shape fill

EUnetHTA Partners and

Collaborative Stakeholders

77 Partner organisations

designated by Ministries of

Health and affiliated entities

Includes large number of

regional agencies and non-for-

profit organisations that produce

or contribute to HTA

ZIN will be the coordinator

Participants in EUnetHTA JA3 (2016-2020)

8


Maximum two

lines in header


for title in Caps




under Shape fill






Top-PowerPoint menu

DG

Sante &

CHAFE

A

€

EUnetHTA

WP 1

Coordination

ZIN

D

I

R

E

C

T

O

R

A

T

E

EUnetHTA Executive Board EUnetHTA Assembly

Member

States

€

WP 2

Dissemination

ISCIII

WP 3

Evaluation

TLV

WP 4

Joint Assessment

NOKC / LBI / ZIN

WP 5

Evidence

HAS / GBA

WP 6

Quality

Management

IQWIQ / KCE

WP 7

National

Implementation

NICE / AGENAS

(4)

(3)

(1)

(2)

(1)

(2)

(1)

(1)

(2)

(1)

(3)

(6)

(2)

(2)

(6)

(3)(1)

(2)

(1)

(3)

(3)

(3)

(3)

(3)

(11)

(1)

(2)

(3)

Liaison Committee

Project

Manager

Group


9


Maximum two

lines in header


for title in Caps






Top-PowerPoint menu

More info on EUnetHTA JA3

May 23, 2016 10



Maximum two

lines in header


for title in Caps




under Shape fill






Top-PowerPoint menu


11

EUnetHTA Coordinator

WP Lead & Co-Lead Partners

Elected Members

Observers (EU Secr.,

etc.)

Grant &

Consortium

Agreement

+ Annexes

PM

Coordination

Committee

EUnetHTA Directorate

EUnetHTA Coordinators

Office

EUnetHTA supporting Secretariat

EUnetHTA Assembly

Meetings decides

Liasion Committee

Observers (EU Secr., etc.)

Elected MS agency

representative

EUnetHTA Coordinatior

supervises

observes

observes

observes


Maximum two

lines in header


for title in Caps




under Shape fill






Top-PowerPoint menu

- WP4 Produce joint and collaborative HTA reports:

- For pharma 37 rapid REA and for other technologies 43 rapid REA

- Horizon scanning

˗ WP5 Evidence Generation

- early dialogues (joint HTA or parallel/joint with regulators)

- additional data collection linked to several activities (adaptive pathways, MEA, etc)

˗ WP6 Quality Management

- Provides quality management for EUnetHTA products

- Further development of electronic tools if necessary

˗ WP7 National implementation and impact

- Supports Member States to implement reports in national setting

- Measure impact of joint work

Summary of activities in EUnetHTA JA3


12


Maximum two

lines in header


for title in Caps




under Shape fill






Top-PowerPoint menu

- Political/strategical level:

- These activities will be moved to the HTA Network

˗ Methodology/processes

- By experts from stakeholders in stakeholder advisory groups (SAGs),

comparable as in JA2

˗ Activities on the level of single/multiple health technologies

- By experts from stakeholders in prioritization/topic selection, scoping

and assessment

- Funding may be available for some stakeholder reps such as patient

representatives and clinicians

Involvement of stakeholders


13


for title and subtitle

in Caps


for text in Caps

Thank you Any questions?

May 23, 2016 14 European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu

Date post:	01-Jun-2020
Category:	Documents
Upload:	others
View:	4 times
Download:	0 times

Progress on EUnetHTA JA3 - European Commission · Presentation title maximum three lines Press...

Documents